research use only

GSK-LSD1 2HCl Histone Demethylase inhibitor

Cat.No.S7574

GSK-LSD1 2HCl is an irreversible, and selective LSD1 inhibitor with IC50 of 16 nM, > 1000 fold selective over other closely related FAD utilizing enzymes (i.e. LSD2, MAO-A, MAO-B).
GSK-LSD1 2HCl Histone Demethylase inhibitor Chemical Structure

Chemical Structure

Molecular Weight: 289.24

Jump to

Quality Control

Batch: S757401 DMSO]57 mg/mL]false]Water]57 mg/mL]false]]]false Purity: 99.78%
  • Cited in Nature Medicine for its top-tier quality
  • COA
  • NMR
  • HPLC
  • SDS
  • Datasheet
99.78

Cell Culture, Treatment & Working Concentration

Cell Lines Assay Type Concentration Incubation Time Formulation Activity Description PMID
A549 Function assay 10 uM 1 hr Binding affinity to LSD1 in human A549 cells assessed as increase in stability of cellular LSD1 protein at 10 uM pre-incubated for 1 hr followed by heating at 49 degC for 3 mins by Western blot-based CESTA 30780087
A549 Function assay 10 uM 1 hr Binding affinity to LSD1 in human A549 cells assessed as increase in stability of cellular LSD1 protein at 10 uM pre-incubated for 1 hr followed by heating at 52 degC for 3 mins by Western blot-based CESTA 30780087
A549 Function assay 96 hrs Down regulation of snail levels in human A549 cells up to 16 uM after 96 hrs by Western blot analysis 30780087
A549 Function assay 96 hrs Down regulation of N-cadherin levels in human A549 cells up to 16 uM after 96 hrs by Western blot analysis 30780087
A549 Function assay 96 hrs Down regulation of slug levels in human A549 cells up to 16 uM after 96 hrs by Western blot analysis 30780087
A549 Function assay 96 hrs Up regulation of claudin-1 levels in human A549 cells up to 16 uM after 96 hrs by Western blot analysis 30780087
A549 Function assay 96 hrs Up regulation of E-cadherin levels in human A549 cells up to 16 uM after 96 hrs by Western blot analysis 30780087
THP1 Function assay 4 uM 3 days Inhibition of LSD1 in human THP1 cells assessed as increase in CD86 expression at 4 uM incubated for 3 days by flow cytometric analysis 31096156
Click to View More Cell Line Experimental Data

Solubility

In vitro
Batch:

DMSO : 57 mg/mL (197.06 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : 57 mg/mL

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Chemical Information, Storage & Stability

Molecular Weight 289.24 Formula

C14H22Cl2N2

Storage (From the date of receipt)
CAS No. 2102933-95-7 Download SDF Storage of Stock Solutions

Synonyms N/A Smiles C1CNCCC1NC2CC2C3=CC=CC=C3.Cl.Cl

Mechanism of Action

Targets/IC50/Ki
LSD1
(Cell-free assay)
16 nM
In vitro

GSK-LSD1 induces gene expression changes in cancer cell lines with average EC50 of < 5 nM and inhibits cancer cell line growth with average EC50 of < 5 nM.

In vivo

GSK-LSD1, a highly selective inhibitor of KDM1A, significantly inhibits thyroid cancer progression and enhances the sensitivity of thyroid cancer to chemotherapy.

References

Applications

Methods Biomarkers Images PMID
Western blot LSD1 / H3K4me2
S7574-WB1
29088714

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Signaling Pathway Map